Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord. SE CONNECTER À UN COMPTE LECTEUR CRÉER UN COMPTE LECTEUR
Coaction Specialty Achieves B Corp Certification
15 mars 2023 11h29 HE
|
Coaction Global
MORRISTOWN, N.J., March 15, 2023 (GLOBE NEWSWIRE) -- Coaction Global, Inc (Coaction), a privately-owned specialty property and casualty (P&C) insurance company, is pleased to announce the...
CNote Closes Series A Investment, Cementing the Women-Led Impact Platform's Leadership in Closing the US Wealth Gap Through Financial Innovation
19 sept. 2022 09h00 HE
|
CNote
OAKLAND, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Building on the momentum of its impact platform—already adopted by corporate leaders including Apple, Mastercard, Netflix and PayPal as a scalable...
Beta Bionics Appoints Sean Saint as CEO and Board Member
15 août 2022 16h00 HE
|
Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational devices limited by Federal (or United States) law to investigational use. Not available for sale. CONCORD, Mass., Aug. 15, 2022 ...
Ferrer Invests More Than 60% of Its Net Profits in Social and Environmental Causes
28 juil. 2022 08h02 HE
|
Ferrer
BARCELONA, Spain, July 28, 2022 (GLOBE NEWSWIRE) -- In 2021 the pharmaceutical company Ferrer invested 61.4% of its net profits in social and environmental causes, as part of its purpose to make a...
The Insulin-Only Bionic Pancreas Pivotal Trial Showed Consistent Mean HbA1c Reductions Across a Variety of Subgroups at ADA’s 82nd Scientific Sessions
09 juin 2022 14h00 HE
|
Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. The randomized Insulin-Only Bionic Pancreas...
CNote's Community Investment Platform Nears $300M, a Sign of Balance Sheet Activism Rising Across Business Sectors
02 juin 2022 09h00 HE
|
CNote Group, Inc.
OAKLAND, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Recent commitments from Apple, Netflix and Xylem have pushed the total funding being deployed to communities via CNote's investment platform to...
Pivotal Trial Results of the iLet® Bionic Pancreas to Be Presented at the ADA’s 82nd Scientific Sessions
01 juin 2022 05h00 HE
|
Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Roy W. Beck will moderate a session: The...
WeTransfer Launches Emerging Creative Hubs Index and $100,000 Grant Program
11 mai 2022 09h00 HE
|
WeTransfer
NEW YORK, May 11, 2022 (GLOBE NEWSWIRE) -- WeTransfer, a leading provider of creative productivity tools announced today the launch of its newest research, the Emerging Creative Hubs Index, and a...
Beta Bionics Appoints Gilad Glick to the Board of Directors and Veena Rao, Ph.D. as Chief Commercial Officer
10 mai 2022 05h00 HE
|
Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Gilad Glick, former Chief Executive Officer,...
CNote Expands Access to Capital for Community Financial Institutions With $25 Million From Apple to Support Communities of Color
05 mai 2022 08h00 HE
|
CNote Group, Inc.
OAKLAND, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Today, CNote, an Oakland-based fintech, announced that Apple will use the CNote platform to deploy $25 million into underserved communities across...